Moneycontrol
HomeNewsBusinessRemote work proponents sniff business opportunities as startups ask employees to work from home
Trending Topics

Remote work proponents sniff business opportunities as startups ask employees to work from home

Founders look for ways to manage and maintain productivity among remote employees, opening opportunities for players like GoScale and Pesto.

March 14, 2020 / 12:36 IST
Story continues below Advertisement

The novel coronavirus fear has gripped India’s Silicon Valley and multiple startups are now opting for 'work from home' for their employees. However, founders and managers are grappling with issues around managing staff and ensuring productivity.

Looking at these developments, companies like GoScale and Pesto are finding fresh business opportunities for offering their services to help smoothen the process.

Story continues below Advertisement

Several companies like insure tech startup Acko, discount broker Zerodha, online micro business enabler Instamojo and credit card company Slice, have all gone remote to prevent the further spread of COVID-19.

India already has over 80 confirmed cases of the virus and at least two officially reported deaths.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show